4.7 Article

Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Ramy Younes et al.

Summary: Lean Caucasian subjects with NAFLD may progress to advanced liver disease, develop metabolic comorbidities, and experience cardiovascular disease and liver-related mortality, independent of longitudinal progression to obesity and PNPLA3 genotype. These patients represent one end of a wide spectrum of phenotypic expression of NAFLD.
Article Endocrinology & Metabolism

Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation

Junzhao Ye et al.

Summary: This study proposes a new classification system for MAFLD that accurately identifies the risk of complications using metabolic parameters. The study found that MAFLD patients in different clusters have different risks of diabetes, heart disease, stroke, and mortality.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Article Endocrinology & Metabolism

Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study

Limin Wei et al.

Summary: The study found that lean NAFLD is associated with an increased risk of incident diabetes, especially more pronounced in women than in men. Further investigations are needed to better understand the natural history of NAFLD in lean subjects.

DIABETES & METABOLISM (2021)

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Editorial Material Gastroenterology & Hepatology

What are the clinical settings and outcomes of lean NAFLD?

Tian-Yi Ren et al.

Summary: A new study has shown that even lean individuals can develop hepatic and extrahepatic complications from nonalcoholic fatty liver disease (NAFLD). This highlights the importance of focusing on metabolic phenotypes in NAFLD assessment, rather than just BMI-based approaches.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges

Mohammad Shafi Kuchay et al.

Summary: Lean/non-obese NAFLD affects a significant portion of the global population and poses a public health concern. Despite similarities in metabolic abnormalities with obese NAFLD, lean NAFLD individuals exhibit differences in genetic predisposition, body composition, gut microbiota, and environmental susceptibility. Current treatment strategies focus on improving overall health and reducing visceral adiposity, with potential pharmacological options being explored for lean NAFLD management.

BIOMEDICINES (2021)

Review Gastroenterology & Hepatology

The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments

Giovanni Targher et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) have a complex relationship with each other, influencing the risk of adverse clinical outcomes. The severity of NAFLD is directly related to the risk of developing T2DM, while improvement of NAFLD may lower the risk of T2DM.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

Giovanni Targher et al.

Summary: NAFLD is not only a global public health issue but also proven to be a systemic disease, closely related to various extrahepatic complications. Addressing NAFLD requires establishing a multidisciplinary working group and framework to achieve comprehensive, person-centered care and management.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease A Systematic Review and Meta-Analysis

Yiwen Shi et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis

Feng-Bin Lu et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Nutrition & Dietetics

Lean non-alcoholic fatty liver disease

Alice Yuxin Wang et al.

CLINICAL NUTRITION (2019)

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

Review Endocrinology & Metabolism

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Amedeo Lonardo et al.

ACTA DIABETOLOGICA (2019)

Review Gastroenterology & Hepatology

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Amedeo Lonardo et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis

Shanhu Qiu et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

NAFLD: A multisystem disease

Christopher D. Byrne et al.

JOURNAL OF HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

Zobair M. Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Review Medical Laboratory Technology

Non-alcoholic fatty liver disease

Briohny W. Smith et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2011)

Article Endocrinology & Metabolism

The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp

Fernando Guerrero-Romero et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Medicine, Research & Experimental

The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects

Luis E. Simental-Mendía et al.

Metabolic Syndrome and Related Disorders (2008)

Article Endocrinology & Metabolism

Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity

A Misra et al.

INTERNATIONAL JOURNAL OF OBESITY (2006)

Article Gastroenterology & Hepatology

The utility of radiological imaging in nonalcoholic fatty liver disease

S Saadeh et al.

GASTROENTEROLOGY (2002)